-
1
-
-
2942642477
-
The prevalence and features of the polycystic ovary syndrome in an unselected population
-
Azziz R., Woods K.S., Reyna R., Key T.J., Knochenhauer E.S., and Yildiz B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89 (2004) 2745-2749
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 2745-2749
-
-
Azziz, R.1
Woods, K.S.2
Reyna, R.3
Key, T.J.4
Knochenhauer, E.S.5
Yildiz, B.O.6
-
2
-
-
33745351339
-
Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
-
Ustun-Engin Y., Ustun Y., Meydanli{dotless} M.M., Kafkasli{dotless} A., and Yetkin G. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?. Gynecol Endocrinol 22 (2006) 324-328
-
(2006)
Gynecol Endocrinol
, vol.22
, pp. 324-328
-
-
Ustun-Engin, Y.1
Ustun, Y.2
Meydanli, M.M.3
Kafkasli, A.4
Yetkin, G.5
-
3
-
-
19944433652
-
Visfatin: a protein secreted by visceral fat that mimics the effects of insulin
-
Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307 (2005) 426-430
-
(2005)
Science
, vol.307
, pp. 426-430
-
-
Fukuhara, A.1
Matsuda, M.2
Nishizawa, M.3
Segawa, K.4
Tanaka, M.5
Kishimoto, K.6
-
4
-
-
25844491778
-
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans
-
Berndt J., Kloting N., Kralisch S., Kovacs P., Fasshauer M., Schon M.R., et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54 (2005) 2911-2916
-
(2005)
Diabetes
, vol.54
, pp. 2911-2916
-
-
Berndt, J.1
Kloting, N.2
Kralisch, S.3
Kovacs, P.4
Fasshauer, M.5
Schon, M.R.6
-
5
-
-
30344471828
-
Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus
-
Chen M.P., Chung F.M., Chang D.M., Tsai J.C.R., Huang H.-F., Shin S.J., et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91 (2006) 295-299
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 295-299
-
-
Chen, M.P.1
Chung, F.M.2
Chang, D.M.3
Tsai, J.C.R.4
Huang, H.-F.5
Shin, S.J.6
-
6
-
-
33845476276
-
Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin
-
Tan B.K., Chen J., Digby J.E., Keay S.D., Kennedy C.R., and Randeva H.S. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin. J Clin Endocrinol Metab 91 (2006) 5022-5028
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 5022-5028
-
-
Tan, B.K.1
Chen, J.2
Digby, J.E.3
Keay, S.D.4
Kennedy, C.R.5
Randeva, H.S.6
-
7
-
-
34547672910
-
Increased plasma visfatin concentrations in women with polycystic ovary syndrome
-
Chan T.F., Chen Y.L., Chen H.H., Lee C.H., Jong S.B., and Tsai E.M. Increased plasma visfatin concentrations in women with polycystic ovary syndrome. Fertil Steril 88 (2007) 401-405
-
(2007)
Fertil Steril
, vol.88
, pp. 401-405
-
-
Chan, T.F.1
Chen, Y.L.2
Chen, H.H.3
Lee, C.H.4
Jong, S.B.5
Tsai, E.M.6
-
8
-
-
34447336403
-
Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome
-
Kowalska I., Straczkowsi M., Nikolajuk A., Adamska A., Karczewska-Kupczewska M., Otziomek E., et al. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 22 (2007) 1824-1829
-
(2007)
Hum Reprod
, vol.22
, pp. 1824-1829
-
-
Kowalska, I.1
Straczkowsi, M.2
Nikolajuk, A.3
Adamska, A.4
Karczewska-Kupczewska, M.5
Otziomek, E.6
-
9
-
-
0346725827
-
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
-
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
-
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
-
(2004)
Fertil Steril
, vol.81
, pp. 19-25
-
-
-
10
-
-
0019424458
-
Hirsutism: implications, etiology and management
-
Hatch R., Rosenfield R.L., Moon H.K., and Tredway D. Hirsutism: implications, etiology and management. Am J Obstet Gynecol 140 (1981) 815-830
-
(1981)
Am J Obstet Gynecol
, vol.140
, pp. 815-830
-
-
Hatch, R.1
Rosenfield, R.L.2
Moon, H.K.3
Tredway, D.4
-
11
-
-
0021813187
-
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
-
Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
Naylor, B.A.4
Treacher, D.F.5
Turner, R.C.6
-
12
-
-
18644365016
-
Insulin resistance in type 2 diabetes-role of adipokines
-
Arner P. Insulin resistance in type 2 diabetes-role of adipokines. Curr Mol Med 5 (2005) 333-339
-
(2005)
Curr Mol Med
, vol.5
, pp. 333-339
-
-
Arner, P.1
-
13
-
-
0034075904
-
Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome
-
Sozen I., and Arici A. Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome. Obstet Gynecol Survey 55 (2000) 321-328
-
(2000)
Obstet Gynecol Survey
, vol.55
, pp. 321-328
-
-
Sozen, I.1
Arici, A.2
-
14
-
-
33646707249
-
Increased visfatin concentrations in women with gestational diabetes mellitus
-
Krzyzanowska K., Krugluger W., Mittermayer F., Rahman R., Haider D., Shnawa N., et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci 110 (2006) 605-609
-
(2006)
Clin Sci
, vol.110
, pp. 605-609
-
-
Krzyzanowska, K.1
Krugluger, W.2
Mittermayer, F.3
Rahman, R.4
Haider, D.5
Shnawa, N.6
-
15
-
-
34147127510
-
Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance
-
Lewandowski K.C., Stojanovic N., Press M., Tuck S.M., Szosland K., Bienkiewicz M., et al. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 50 (2007) 1033-1037
-
(2007)
Diabetologia
, vol.50
, pp. 1033-1037
-
-
Lewandowski, K.C.1
Stojanovic, N.2
Press, M.3
Tuck, S.M.4
Szosland, K.5
Bienkiewicz, M.6
-
16
-
-
33745789837
-
The release of the adipocytokine visfatin is regulated by glucose and insulin
-
Haider D.G., Schaller G., Kapiotis S., Maier C., Luger A., and Wolzt M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 46 (2006) 1909-1914
-
(2006)
Diabetologia
, vol.46
, pp. 1909-1914
-
-
Haider, D.G.1
Schaller, G.2
Kapiotis, S.3
Maier, C.4
Luger, A.5
Wolzt, M.6
-
17
-
-
34347387742
-
Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus
-
Hsieh C.H., He C.T., Lee C.H., Wu L.Y., and Hung Y.J. Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus. Metabolism 56 (2007) 1087-1092
-
(2007)
Metabolism
, vol.56
, pp. 1087-1092
-
-
Hsieh, C.H.1
He, C.T.2
Lee, C.H.3
Wu, L.Y.4
Hung, Y.J.5
-
18
-
-
33947247655
-
Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus
-
Takebayashi K., Suetsugu M., Wakabayashi S., Aso Y., and Inukai T. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 56 (2007) 451-458
-
(2007)
Metabolism
, vol.56
, pp. 451-458
-
-
Takebayashi, K.1
Suetsugu, M.2
Wakabayashi, S.3
Aso, Y.4
Inukai, T.5
-
19
-
-
0034111902
-
Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome
-
Kolodziejczyk B., Duleba A.J., Spaczynski R.Z., and Pawelczyk L. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril 73 (2000) 1149-1154
-
(2000)
Fertil Steril
, vol.73
, pp. 1149-1154
-
-
Kolodziejczyk, B.1
Duleba, A.J.2
Spaczynski, R.Z.3
Pawelczyk, L.4
-
20
-
-
0031957333
-
Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome
-
Diamanti-Kandarakis E. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol 138 (1998) 269-274
-
(1998)
Eur J Endocrinol
, vol.138
, pp. 269-274
-
-
Diamanti-Kandarakis, E.1
-
21
-
-
34248593022
-
Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance
-
Nawrocka J., and Starczewski A. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance. Gynecol Endocrinol 23 (2007) 231-237
-
(2007)
Gynecol Endocrinol
, vol.23
, pp. 231-237
-
-
Nawrocka, J.1
Starczewski, A.2
-
22
-
-
0142247208
-
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
-
Lord J.M., Flight I.H., and Norman R.J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Br Med J 327 (2003) 951-957
-
(2003)
Br Med J
, vol.327
, pp. 951-957
-
-
Lord, J.M.1
Flight, I.H.2
Norman, R.J.3
|